az-628 and Adrenocortical-Carcinoma

az-628 has been researched along with Adrenocortical-Carcinoma* in 1 studies

Other Studies

1 other study(ies) available for az-628 and Adrenocortical-Carcinoma

Article	Year
The underlying molecular mechanism and drugs for treatment in adrenal cortical carcinoma. International journal of medical sciences, 2021, Volume: 18, Issue:13 Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Adult; Biomarkers, Tumor; Chemotherapy, Adjuvant; Computational Biology; Databases, Genetic; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Isoquinolines; Kaplan-Meier Estimate; Male; MicroRNAs; Middle Aged; Prognosis; Protein Kinase Inhibitors; Quinazolines; RNA-Seq; RNA, Messenger; Succinimides; Sulfonamides	2021

Article

Year

The underlying molecular mechanism and drugs for treatment in adrenal cortical carcinoma.

International journal of medical sciences, 2021, Volume: 18, Issue:13

Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Adult; Biomarkers, Tumor; Chemotherapy, Adjuvant; Computational Biology; Databases, Genetic; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Isoquinolines; Kaplan-Meier Estimate; Male; MicroRNAs; Middle Aged; Prognosis; Protein Kinase Inhibitors; Quinazolines; RNA-Seq; RNA, Messenger; Succinimides; Sulfonamides

2021